Minapharm Pharmaceuticals
- 221.78 EGP
- -3.70
- -1.64%
Minapharm Pharmaceuticals Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 221.78 |
| Prev. Close | 225.480 |
| Day Range | 212.00 - 221.94 |
| 52WK range | |
| Turnover (M EGP) | 0.06 |
| Volume (M) | 0.00 |
| Number of Trades | 11 |
| Market Cap (M EGP) | 3,159.41 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 0.00 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Minapharm Pharmaceuticals’ shareholders nod to 2022...
Cairo - Mubasher: The shareholders of Minapharm Pharmaceuticals greenlighted a cash dividend distribution worth EGP 2.80 per share for 2022.The general...
Minapharm Pharmaceuticals mulls EGP 603m capital hike
Cairo - Mubasher: The board of Minapharm Pharmaceuticals agreed to increase the company’s issued capital by EGP 602.98 million through bonus shares,...
Bioventure, Minapharm, MiGenTra to commercialise multiple...
Mubasher: Dubai-based Bioventure, Minapharm Pharmaceuticals, and MiGenTra GmbH have signed an exclusive licence agreement for the commercialisation of...
Minapharm sees 75% higher consolidated profits in 9M
Cairo – Mubasher: Minapharm Pharmaceuticals' consolidated net profits jumped by 75.1% to EGP 352.36 million in the first nine...
Minapharm Pharmaceuticals reports 135% standalone profit...
Cairo – Mubasher: Minapharm Pharmaceuticals reported standalone net profits of EGP 225.63 million in the first nine months of 2021, up by 134.8%...
